Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LIPF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SHOC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BGN - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
C16orf70 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SEMA5A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ACTG1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
ANK3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PFDN1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EPAS1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
UTP18 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RCAN3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ADD3-AS1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
YTHDC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HNRNPA3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Profile neighbors
UBE2K - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NSD1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SPINT2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NCOR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on